265 related articles for article (PubMed ID: 7332041)
21. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
Soucek K
Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
[No Abstract] [Full Text] [Related]
22. [Mianserin: review and discussion of its double-blind studies versus nomifensine].
Montogomery SA; Rani SJ; Roy D; Montgomery DB
Encephale; 1981; 7(4 Suppl):485-94. PubMed ID: 7032888
[No Abstract] [Full Text] [Related]
23. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of nomifensine in different depressive syndromes.
Overall JE
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):85-8. PubMed ID: 6370983
[TBL] [Abstract][Full Text] [Related]
25. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
Siegfried K; O'Connolly M
Int Clin Psychopharmacol; 1986 Jul; 1(3):231-43. PubMed ID: 3549874
[No Abstract] [Full Text] [Related]
26. Nomifensine in the treatment of depressed geriatric patients.
Goldstein SE; Birnbom F; Laliberte R
J Clin Psychiatry; 1982 Jul; 43(7):287-9. PubMed ID: 7045090
[TBL] [Abstract][Full Text] [Related]
27. Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
Ridges AP
Postgrad Med J; 1977; 53 Suppl 4():24-9. PubMed ID: 341107
[No Abstract] [Full Text] [Related]
28. Maprotiline in pain-depression.
Lindsay PG; Olsen RB
J Clin Psychiatry; 1985 Jun; 46(6):226-8. PubMed ID: 3888970
[TBL] [Abstract][Full Text] [Related]
29. Clinical experience with maprotilin and maprotilin/clomipramine infusions in resistant depression.
Zapletálek M; Zbytovský J; Kudrnová K
Act Nerv Super (Praha); 1982 May; 24(2):73-6. PubMed ID: 7102227
[TBL] [Abstract][Full Text] [Related]
30. Viloxazine in the treatment of depression: psychophysical measures and clinical response.
Amin MM; Ban TA; Lehmann HE; Khan P
Psychopharmacol Bull; 1978 Jan; 14(1):33-5. PubMed ID: 625536
[No Abstract] [Full Text] [Related]
31. Trimipramine and maprotiline: antidepressant, anxiolytic, and cardiotoxic comparison.
Pecknold JC; Familamiri P; McClure DJ; Elie R; Chang H
J Clin Psychiatry; 1985 May; 46(5):166-71. PubMed ID: 2859273
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of depressive conditions with viloxazine by the general practitioner].
Haehn KD
Fortschr Med; 1985 Apr; 103(15):408-12. PubMed ID: 3997018
[No Abstract] [Full Text] [Related]
33. [Use of maprotiline in primary and secondary anxio-depressive syndromes in the aged].
Volpi F
Clin Ter; 1983 Jul; 106(2):95-101. PubMed ID: 6627888
[No Abstract] [Full Text] [Related]
34. [Study of nomifensine in the treatment of depressive states (author's transl)].
Zermatten A; Cumps J
Acta Psychiatr Belg; 1981; 81(4):379-98. PubMed ID: 7036657
[TBL] [Abstract][Full Text] [Related]
35. Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
Adv Biochem Psychopharmacol; 1982; 32():369-73. PubMed ID: 7090902
[No Abstract] [Full Text] [Related]
36. [Clinical considerations regarding the use of maprotiline in psychiatric treatment].
Pirozynski T; Chiriţă V; Mungiu OC; Cosmovici N; Boişteanu P
Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):251-5. PubMed ID: 3685686
[No Abstract] [Full Text] [Related]
37. [The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
Binz U; Wendt G
Fortschr Med; 1982 Dec; 100(45):2111-7. PubMed ID: 6757074
[No Abstract] [Full Text] [Related]
38. [Clinical trials of viloxazine in depressive states].
Fontan M; Goudemand M; Pellerin-Millecamps E
Encephale; 1979; 5(3):243-9. PubMed ID: 385296
[No Abstract] [Full Text] [Related]
39. Nomifensine: the preclinical and clinical profile of a second generation antidepressant.
J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):1-105. PubMed ID: 6370968
[No Abstract] [Full Text] [Related]
40. Multicentre study with viloxazine (Vivalan) in depressed patients.
Kabes J; Dostal T; Náhunek K; Svestka J; Molcan J; Caplová T; Hynek K; Faltus F; Holland RP
Int Pharmacopsychiatry; 1980; 15(4):228-39. PubMed ID: 7021448
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
